3557 results for «253»

Filter By

3557 results

Heart team discussion for left main PCI

14 May 2024 – From EuroPCR 2024

This session focuses on the role of the heart team in the management of complex left main coronary artery disease. It presents three cases, each with a unique set of challenges, and facilitates a structured discussion with the audience to arrive at the optimal treatment strategy....

Heart team discussion for left main PCI

Acute coronary syndromes caused by left main coronary lesions requiring emergency intervention

15 May 2024 – From EuroPCR 2024

Acute coronary syndromes caused by left main coronary lesions requiring emergency intervention

DCB PCI for de novo lesions: when and how?

15 May 2024 – From EuroPCR 2024

In this session, you will learn how to optimally perform DCB PCI, identify which lesions are best suited for this approach, and understand when it's necessary to switch from DCB to stent PCI. The session also features a debate on whether DCB-PCI should be the first...

DCB PCI for de novo lesions: when and how?

PCR's Got Talent - Round 1 - Session 2

14 May 2024 – From EuroPCR 2024

This session is part of the "PCR's Got Talent" competition, showcasing a diverse range of abstract submissions covering various aspects of interventional cardiology. The topics include the impact of bifurcation lesions on outcomes in the FAME 3 trial, predictors of target lesion failure after DCB angioplasty,...

PCR's Got Talent - Round 1 - Session 2

What about MINOCA?

14 May 2024 – From EuroPCR 2024

This session focuses on the topic of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA). It covers the mechanisms underlying MINOCA, the criteria for its diagnosis, and the management of patients with this condition. The session provides insights from both the clinician's and the patient's perspectives, addressing...

What about MINOCA?

Major Late-Breaking Trials from EuroPCR 2024

15 May 2024 – From EuroPCR 2024

This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...

Major Late-Breaking Trials from EuroPCR 2024

It's not all about the anatomy - When physiology matters!

14 May 2024 – From EuroPCR 2024

This session, in collaboration with various international cardiology societies, emphasizes the importance of physiology-guided interventions in complex multivessel disease. It presents three cases demonstrating the use of CTCA-derived cFFR, pressure wire assessment in bifurcation PCI, and angio-based FFR to guide treatment decisions. The discussions highlight how...

It's not all about the anatomy - When physiology matters!

Aortic valve-in-valve or TAV-in-TAV challenges

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the challenges of aortic valve-in-valve or TAV-in-TAV procedures. The session will feature various complex cases, including when even two surgeries are not enough, resilient rhythms in geriatric resurgence, valve-in-valve TAVI for degenerated small surgical bioprosthetic...

Aortic valve-in-valve or TAV-in-TAV challenges

Antegrade CTO PCI: how to develop a consistent and systematic strategy ?

14 May 2024 – From EuroPCR 2024

This replay provides a comprehensive guide to mastering antegrade wire escalation (AWE), managing failed procedures, and utilizing IVUS to address ambiguous proximal caps. Additionally, learn when to stop in the event of a failed case and explore alternative strategies to ensure optimal patient outcomes.

Antegrade CTO PCI: how to develop a consistent and systematic strategy ?

Calcified coronary lesions: procedural techniques

15 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on procedural techniques for the management of calcified coronary lesions. It will feature various complex cases, including in-stent shave and debulk, damned coronary nodules, rotatripsy burring before the shock, protected high-risk PCI of a heavily calcified...

Calcified coronary lesions: procedural techniques

Second generation biolimus drug-coated balloon in clinical practice

15 May 2024 – From EuroPCR 2024

Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel,...

Second generation biolimus drug-coated balloon in clinical practice

The future of interventional cardiology imaging

15 May 2024 – From EuroPCR 2024

Explore this session to discover the latest innovations in interventional cardiology images, including the benefits of artificial intelligence and angio-CT in PCI/SHD procedures. Learn about Alphenix Evolve and the initial experiences with AI imaging in daily cathlab practice, alongside intraprocedural angio-CT guided LAAO, and engage in...

The future of interventional cardiology imaging

PCI in patients with diabetes: next generation DES + DCB stent platform in action

14 May 2024 – From EuroPCR 2024

Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...

PCI in patients with diabetes: next generation DES + DCB stent platform in action

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

16 May 2024 – From EuroPCR 2024

Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions

15 May 2024 – From EuroPCR 2024

Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...

Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions

Identification and treatment of (sub)clinical transcatheter valve thrombosis

16 May 2024 – From EuroPCR 2024

This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...

Identification and treatment of (sub)clinical transcatheter valve thrombosis

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

14 May 2024 – From EuroPCR 2024

Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

PASCAL Precision system simulation showcase: grasp the difference!

16 May 2024 – From EuroPCR 2024

In this EuroPCR 2024 session, explore a transcatheter edge-to-edge mitral valve repair case, delve into discussions backed by simulation, evidence, and real-world cases to understand atraumatic clasp and closure techniques and predictable implant release. Additionally, gain insights into real-world evidence for tricuspid TEER from the EuroTR trial...

PASCAL repair system simulation showcase: grasp the difference!

Restoring vessel physiology drives outcomes - The Bioadaptor experience

16 May 2024 – From EuroPCR 2024

Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...

Restoring vessel physiology drives outcomes - The Bioadaptor experience

TAVI in TAVI - LIVE case

14 May 2024 – From EuroPCR 2024

A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...

TAVI for degenerated aortic bioprosthesis
Didn’t find what you were looking for?